Cancer Immunology, Immunotherapy

Published by: Springer  

People

  1. Cheung
    Cheung
  2. Modak
    Modak
  3. Vickers
    Vickers

Groups

  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)
  2. Center for Molecular Imaging and Biotechnology (1)
  3. Epidemiology and Biostatistics (1)
  4. GSK Faculty (1)
  5. Health Outcomes Research Group (1)
  6. Neuroblastoma Service (1)
  7. Pediatrics, Department of (1)
  8. Population Sciences Research Program (1)
  9. Tow Center for Developmental Oncology (TCDO) (1)

Cancer Immunology, Immunotherapy – authorized name for:

Name ISSN / ISBN Publisher
Cancer Immunology and Immunotherapy 978-3-642-14136-2 Springer Verlag
Cancer Immunology Immunotherapy 0340-7004 Springer
Cancer Immunology Immunotherapy 0340-7004 Unknown
Cancer Immunology Immunotherapy 0340-7004 Springer
Cancer Immunology Immunotherapy 0340-7004 Springer
Cancer Immunology Immunotherapy 0340-7004 Springer Verlag
Cancer Immunology Immunotherapy 03407004 Springer Verlag
Cancer Immunology Immunotherapy 03407004 Unknown
Cancer Immunology Immunotherapy 0340-7004 Springer Verlag
Cancer Immunology, Immunotherapy 0340-7004 Springer Verlag
Cancer Immunology, Immunotherapy 0340-7004 Springer Verlag
Cancer Immunology, Immunotherapy 0340-7004 Springer
Cancer Immunology, Immunotherapy 0340-7004 Springer
Cancer Immunology, Immunotherapy 03407004 Springer Verlag
Cancer Immunology, Immunotherapy 0340-7004 Springer
Cancer Immunology, Immunotherapy 03407004 2022, The Author(s), Under Exclusive Licence To Springer Verlag Gmbh Germany, Part of Springer Nature
Cancer Immunology, Immunotherapy 03407004 Springer Verlag
Cancer Immunology, Immunotherapy 03407004 Springer Verlag
Cancer Immunology, Immunotherapy 03407004 2018, Springer Verlag Gmbh Germany, Part of Springer Nature
Cancer Immunology, Immunotherapy 03407004 2019, The Author(s)
Cancer Immunology, Immunotherapy 03407004 Springer Verlag
Cancer Immunology, Immunotherapy 03407004 The Author(s)
Cancer Immunology, Immunotherapy 03407004 2022, The Author(s)
Cancer Immunology, Immunotherapy 03407004 2023, The Author(s)
Cancer Immunology, Immunotherapy 03407004 2023, The Author(s), Under Exclusive Licence To Springer Verlag Gmbh Germany, Part of Springer Nature
Cancer Immunology, Immunotherapy 03407004 Springer Verlag
Cancer Immunology, Immunotherapy 03407004 Springer Verlag Berlin Heidelberg
Cancer Immunology, Immunotherapy 03407004 Springer Verlag Berlin Heidelberg
Cancer Immunology, Immunotherapy 03407004 The Author(s) 2024
Cancer Immunology, Immunotherapy 0340-7004 Springer
Cancer Immunology, Immunotherapy 03407004 Springer Verlag
Cancer Immunology, Immunotherapy 0340-7004 Springer
Cancer Immunology, Immunotherapy 0340-7004 Springer
Cancer Immunology, Immunotherapy 03407004 Unknown
Cancer Immunology, Immunotherapy 03407004 Us Government